Omniab earnings were -$62.0M for the trailing 12 months ending Dec 31, 2024, with N/A growth year over year. The latest OABI earnings report on Dec 31, 2024 announced Q4 2024 earnings of -$13.1M, down 20.2% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, OABI reported annual earnings of -$62.0M, with 22.5% growth. The next OABI earnings date is May 7, 2025.
On OABI's earnings call on Invalid Date, Omniab (NASDAQ: OABI) reported Q4 2024 earnings per share (EPS) of -$0.13, up 7.14% year over year. Total OABI earnings for the quarter were -$13.07 million. In the same quarter last year, Omniab's earnings per share (EPS) was -$0.14.
The next OABI earnings call is Invalid Date. Add OABI to your watchlist to be reminded of Omniab's next earnings date.
What was OABI's earnings growth in the past year?
As of Omniab's earnings date in Invalid Date, Omniab's earnings has grown year over year. OABI earnings in the past year totalled -$62.03 million.
Is Omniab profitable or losing money?
As of the last Omniab earnings report, Omniab is currently losing money. Omniab's net profit (also called net income) for the twelve months ending Dec 31, 2024 was -$62.03 million, a 22.55% increase year over year.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.